Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
European Journal of Pharmacology
|
April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
D H Albert, T J Magoc, P Tapang, et al.
Archives of Pathology & Laboratory Medicine
|
July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens
Aziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
V A Miller, F M Benedetti, J R Rigas, et al.
JAMA
|
April 10, 2003
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study
Mark P Ettinger, Thomas W Littlejohn, Sherwyn L Schwartz, et al.
Biochemical and Biophysical Research Communications
|
November 16, 2004
Differential protein acetylation induced by novel histone deacetylase inhibitors
K B Glaser, J Li, L J Pease, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 13, 2020
Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors
John T Randolph, Tongmei Li, A Chris Krueger, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors
D H Steinman, M L Curtin, R B Garland, et al.
Journal of Enzyme Inhibition
|
October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitors
P A Marcotte, I N Elmore, Z Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program
P McLaughlin, A J Grillo-López, B K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
P McLaughlin, A J Grillo-López, B K Link, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
European Journal of Pharmacology
|
April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
D H Albert, T J Magoc, P Tapang, et al.
Archives of Pathology & Laboratory Medicine
|
July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens
Aziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
V A Miller, F M Benedetti, J R Rigas, et al.
JAMA
|
April 10, 2003
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study
Mark P Ettinger, Thomas W Littlejohn, Sherwyn L Schwartz, et al.
Biochemical and Biophysical Research Communications
|
November 16, 2004
Differential protein acetylation induced by novel histone deacetylase inhibitors
K B Glaser, J Li, L J Pease, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 13, 2020
Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors
John T Randolph, Tongmei Li, A Chris Krueger, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors
D H Steinman, M L Curtin, R B Garland, et al.
Journal of Enzyme Inhibition
|
October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitors
P A Marcotte, I N Elmore, Z Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program
P McLaughlin, A J Grillo-López, B K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
P McLaughlin, A J Grillo-López, B K Link, et al.
Page
of 8